Associated Papers
ADA2 is a lysosomal deoxyadenosine deaminase acting on DNA involved in regulating TLR9-mediated immune sensing of DNA.
Greiner-Tollersrud OK et al.
Cell Reports, 2024
Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.
Pilania RK et al.
Frontiers in Immunology, 2022
A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience.
Rama M et al.
European Journal of Human Genetics : Ejhg, 2018
Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
Meyts I et al.
Journal of Clinical Immunology, 2018
Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.
Sahin S et al.
Rheumatology International, 2018
Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
Hashem H et al.
Current Rheumatology Reports, 2017
Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood.
Schepp J et al.
Arthritis & Rheumatology (hoboken, N.j.), 2017
Monogenic polyarteritis: the lesson of ADA2 deficiency.
Caorsi R et al.
Pediatric Rheumatology Online Journal, 2016
Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency.
Schepp J et al.
Journal of Clinical Immunology, 2016
Select a paper to view details